Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus By Reuters
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 16 2025
0mins
Source: Investing.com
Novo Holdings' Acquisition Plans: Novo Holdings aims to double the size of Catalent, a recently acquired contract drugmaker, over five years, following a $16.5 billion acquisition deal and subsequent sale of manufacturing plants to Novo Nordisk.
Impact of U.S. Manufacturing Focus: With President-elect Donald Trump's anticipated policies favoring U.S. manufacturing, more drugmakers may shift from overseas suppliers to American service providers, potentially benefiting companies like Catalent and Thermo Fisher Scientific.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TMO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TMO
Wall Street analysts forecast TMO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TMO is 658.89 USD with a low forecast of 580.00 USD and a high forecast of 750.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
19 Analyst Rating
18 Buy
1 Hold
0 Sell
Strong Buy
Current: 542.830
Low
580.00
Averages
658.89
High
750.00
Current: 542.830
Low
580.00
Averages
658.89
High
750.00
About TMO
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nvidia Shares Up 47% with Promising Growth Ahead
- Strong Market Demand: Nvidia's (NVDA) stock has surged 47% over the past year, driven by ongoing investments in chips and data centers, particularly as Google's parent company Alphabet announced a minimum of $175 billion in capital expenditures this year to support AI demand, indicating robust market interest in artificial intelligence.
- Diversified Market Opportunities: Nvidia is not solely reliant on selling powerful chips to AI hyperscalers; it is also partnering with Thermo Fisher Scientific to build an AI lab computing system powered by its DGX Spark supercomputer, targeting the life sciences industry, which spends approximately $300 billion annually on research and development, thereby expanding its market potential.
- Systems Solutions Provider: Nvidia distinguishes itself as a systems and solutions provider rather than just a chip supplier, which enhances its competitive edge against custom chip designers like Broadcom, making it an indispensable partner for enterprises seeking to solve complex problems and solidifying its market position.
- Attractive Investment Value: Nvidia's stock appears attractively valued, trading at 24 times this year's consensus earnings estimate, with Wall Street analysts projecting a 57% increase in earnings this year, suggesting that the recent dip could present an excellent buying opportunity before the stock rises to new highs later this year.
See More
Nvidia Expands Competitive Lead in AI Market
- Surge in Capital Expenditure: Alphabet, Google's parent company, announced it will invest at least $175 billion in capital expenditures this year to support AI demand, indicating sustained enthusiasm for AI investments that further boosts Nvidia's market demand.
- Market Potential Expansion: Nvidia is not solely reliant on selling powerful chips to AI hyperscalers like Google; it is partnering with Thermo Fisher Scientific to build AI lab computing systems, which is expected to tap into the $300 billion market opportunity in the life sciences sector.
- Optimistic Earnings Outlook: Analysts project Nvidia's earnings to grow by 57% this year, with the stock currently trading at 24 times this year's consensus earnings estimate, making it an attractive investment option for investors looking for value.
- Strengthened Industry Position: Nvidia is not just a chip supplier but a systems and solutions provider, solidifying its indispensable role in the AI sector by solving complex problems, thereby differentiating itself from custom chip designers like Broadcom.
See More
OpenAI Launches New Enterprise Platform Frontier to Enhance AI Integration
- Platform Launch: OpenAI announced the launch of its new enterprise platform, Frontier, designed to streamline the management and deployment of AI agents by integrating disparate systems and data within organizations, thereby enhancing operational efficiency for business customers.
- Accelerated Market Penetration: Currently, OpenAI has over 1 million enterprise customers, with expectations to increase the proportion of enterprise clients from 40% to nearly 50% by year-end, indicating strong growth potential in the enterprise market.
- Collaborative Ecosystem: OpenAI emphasizes that the Frontier platform will be built in collaboration with various partners, supporting both self-built agents by enterprises and those from third parties like Google, Microsoft, and Anthropic, showcasing the company's openness and flexibility within the AI ecosystem.
- Initial User Feedback: Frontier is initially being rolled out to a select group of customers, including Uber, State Farm, Intuit, and Thermo Fisher, with broader availability expected in the coming months, which is likely to further drive enterprise transformation and upgrades in AI applications.
See More
OpenAI Launches New Enterprise Platform Frontier
- Enterprise Customer Growth: OpenAI CFO Sarah Friar noted that enterprise customers currently account for 40% of the company's business, with expectations to reach 50% by year-end, indicating successful execution of its expansion strategy in the enterprise market.
- Frontier Platform Features: The newly launched Frontier platform acts as an intelligence layer that integrates disparate systems and data within organizations, simplifying the management and deployment of AI agents, thereby enhancing operational efficiency and task execution capabilities.
- Partner Ecosystem: OpenAI CEO Fidji Simo emphasized that the launch of Frontier reflects the necessity of collaborating with an ecosystem, as enterprises require diverse partners to meet their AI needs, showcasing OpenAI's flexibility and adaptability in the market.
- Initial User Feedback: The Frontier platform has been rolled out to a select few customers, including Uber, State Farm, Intuit, and Thermo Fisher, with broader availability expected in the coming months, signaling OpenAI's deeper penetration into the enterprise market.
See More
C WorldWide Increases Stake in MercadoLibre by 517%
- Stake Increase: C WorldWide Group Holding A/S purchased an additional 44,747 shares of MercadoLibre in Q4 2026, with an estimated transaction value of approximately $93.99 million, indicating strong confidence in the Latin American market.
- Position Value Growth: The fund's quarter-end position value in MercadoLibre increased by $87.34 million, reflecting positive market expectations for the company despite its stock underperforming over the past year.
- Competitive Pressure: While MercadoLibre faces competitive pressures from Amazon and others, its fintech arm is actively addressing the rise in nonperforming loans, demonstrating the company's resilience in challenging conditions.
- Economic Recovery Opportunities: The rapid improvement in Argentina's economy and leadership changes in Venezuela may present new growth opportunities for MercadoLibre, and although its P/E ratio stands at 51, it remains attractive compared to Amazon's historical multiples.
See More
Revvity Reports Strong Q4 2025 Earnings, Exceeds Expectations
- Earnings Growth: Revvity reported adjusted earnings of $1.70 per share for Q4 2025, a 19.7% year-over-year increase that surpassed the consensus estimate of $1.55, indicating robust profitability and competitive strength.
- Sales Increase: The company achieved sales of $772.06 million, up 6% year-over-year with 4% organic growth, exceeding the market expectation of $761.29 million, reflecting sustained demand for its products in the market.
- Life Sciences Segment Performance: The Life Sciences segment generated $382 million in revenue, a 2% increase, although academic and government demand declined, the growth from pharma and biotech partially offset this, showcasing the segment's resilience.
- Future Guidance: Revvity forecasts adjusted earnings for fiscal 2026 to be between $5.35 and $5.45 per share, with sales projected at $2.96 billion to $2.99 billion, reflecting a year-over-year growth of 4%-5%, indicating the company's confidence and strategic planning for future market conditions.
See More
Nvidia Shares Up 47% with Promising Growth Ahead
- Strong Market Demand: Nvidia's (NVDA) stock has surged 47% over the past year, driven by ongoing investments in chips and data centers, particularly as Google's parent company Alphabet announced a minimum of $175 billion in capital expenditures this year to support AI demand, indicating robust market interest in artificial intelligence.
- Diversified Market Opportunities: Nvidia is not solely reliant on selling powerful chips to AI hyperscalers; it is also partnering with Thermo Fisher Scientific to build an AI lab computing system powered by its DGX Spark supercomputer, targeting the life sciences industry, which spends approximately $300 billion annually on research and development, thereby expanding its market potential.
- Systems Solutions Provider: Nvidia distinguishes itself as a systems and solutions provider rather than just a chip supplier, which enhances its competitive edge against custom chip designers like Broadcom, making it an indispensable partner for enterprises seeking to solve complex problems and solidifying its market position.
- Attractive Investment Value: Nvidia's stock appears attractively valued, trading at 24 times this year's consensus earnings estimate, with Wall Street analysts projecting a 57% increase in earnings this year, suggesting that the recent dip could present an excellent buying opportunity before the stock rises to new highs later this year.
See More
Nvidia Expands Competitive Lead in AI Market
- Surge in Capital Expenditure: Alphabet, Google's parent company, announced it will invest at least $175 billion in capital expenditures this year to support AI demand, indicating sustained enthusiasm for AI investments that further boosts Nvidia's market demand.
- Market Potential Expansion: Nvidia is not solely reliant on selling powerful chips to AI hyperscalers like Google; it is partnering with Thermo Fisher Scientific to build AI lab computing systems, which is expected to tap into the $300 billion market opportunity in the life sciences sector.
- Optimistic Earnings Outlook: Analysts project Nvidia's earnings to grow by 57% this year, with the stock currently trading at 24 times this year's consensus earnings estimate, making it an attractive investment option for investors looking for value.
- Strengthened Industry Position: Nvidia is not just a chip supplier but a systems and solutions provider, solidifying its indispensable role in the AI sector by solving complex problems, thereby differentiating itself from custom chip designers like Broadcom.
See More
OpenAI Launches New Enterprise Platform Frontier to Enhance AI Integration
- Platform Launch: OpenAI announced the launch of its new enterprise platform, Frontier, designed to streamline the management and deployment of AI agents by integrating disparate systems and data within organizations, thereby enhancing operational efficiency for business customers.
- Accelerated Market Penetration: Currently, OpenAI has over 1 million enterprise customers, with expectations to increase the proportion of enterprise clients from 40% to nearly 50% by year-end, indicating strong growth potential in the enterprise market.
- Collaborative Ecosystem: OpenAI emphasizes that the Frontier platform will be built in collaboration with various partners, supporting both self-built agents by enterprises and those from third parties like Google, Microsoft, and Anthropic, showcasing the company's openness and flexibility within the AI ecosystem.
- Initial User Feedback: Frontier is initially being rolled out to a select group of customers, including Uber, State Farm, Intuit, and Thermo Fisher, with broader availability expected in the coming months, which is likely to further drive enterprise transformation and upgrades in AI applications.
See More
OpenAI Launches New Enterprise Platform Frontier
- Enterprise Customer Growth: OpenAI CFO Sarah Friar noted that enterprise customers currently account for 40% of the company's business, with expectations to reach 50% by year-end, indicating successful execution of its expansion strategy in the enterprise market.
- Frontier Platform Features: The newly launched Frontier platform acts as an intelligence layer that integrates disparate systems and data within organizations, simplifying the management and deployment of AI agents, thereby enhancing operational efficiency and task execution capabilities.
- Partner Ecosystem: OpenAI CEO Fidji Simo emphasized that the launch of Frontier reflects the necessity of collaborating with an ecosystem, as enterprises require diverse partners to meet their AI needs, showcasing OpenAI's flexibility and adaptability in the market.
- Initial User Feedback: The Frontier platform has been rolled out to a select few customers, including Uber, State Farm, Intuit, and Thermo Fisher, with broader availability expected in the coming months, signaling OpenAI's deeper penetration into the enterprise market.
See More
C WorldWide Increases Stake in MercadoLibre by 517%
- Stake Increase: C WorldWide Group Holding A/S purchased an additional 44,747 shares of MercadoLibre in Q4 2026, with an estimated transaction value of approximately $93.99 million, indicating strong confidence in the Latin American market.
- Position Value Growth: The fund's quarter-end position value in MercadoLibre increased by $87.34 million, reflecting positive market expectations for the company despite its stock underperforming over the past year.
- Competitive Pressure: While MercadoLibre faces competitive pressures from Amazon and others, its fintech arm is actively addressing the rise in nonperforming loans, demonstrating the company's resilience in challenging conditions.
- Economic Recovery Opportunities: The rapid improvement in Argentina's economy and leadership changes in Venezuela may present new growth opportunities for MercadoLibre, and although its P/E ratio stands at 51, it remains attractive compared to Amazon's historical multiples.
See More
Revvity Reports Strong Q4 2025 Earnings, Exceeds Expectations
- Earnings Growth: Revvity reported adjusted earnings of $1.70 per share for Q4 2025, a 19.7% year-over-year increase that surpassed the consensus estimate of $1.55, indicating robust profitability and competitive strength.
- Sales Increase: The company achieved sales of $772.06 million, up 6% year-over-year with 4% organic growth, exceeding the market expectation of $761.29 million, reflecting sustained demand for its products in the market.
- Life Sciences Segment Performance: The Life Sciences segment generated $382 million in revenue, a 2% increase, although academic and government demand declined, the growth from pharma and biotech partially offset this, showcasing the segment's resilience.
- Future Guidance: Revvity forecasts adjusted earnings for fiscal 2026 to be between $5.35 and $5.45 per share, with sales projected at $2.96 billion to $2.99 billion, reflecting a year-over-year growth of 4%-5%, indicating the company's confidence and strategic planning for future market conditions.
See More
